Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 44, Issue 1, Pages 285-294
Publisher
Spandidos Publications
Online
2013-11-05
DOI
10.3892/ijo.2013.2167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aurora kinase inhibitor AZD1152 has an additional effect of platinum on a sequential application at the human ovarian cancer cell line SKOV3
- (2013) Yaxi Ma et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines
- (2012) Ali Sak et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells
- (2012) Caroline Bonet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Contemporary management of endometrial cancer
- (2012) Jason D Wright et al. LANCET
- Aurora-C kinase supports mitotic progression in the absence of Aurora-B
- (2011) Scott D. Slattery et al. CELL CYCLE
- Radiation in vulvar cancer
- (2011) Daya Nand Sharma CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells
- (2011) Kleiton Silva Borges et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
- (2011) F. Marampon et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced Radiosensitivity of Androgen-Resistant Prostate Cancer: AZD1152-Mediated Aurora Kinase B Inhibition
- (2011) Kenneth J Niermann et al. RADIATION RESEARCH
- Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
- (2010) A. A. Dar et al. MOLECULAR CANCER THERAPEUTICS
- Mitotic drivers—inhibitors of the Aurora B Kinase
- (2009) Nicholas Keen et al. CANCER AND METASTASIS REVIEWS
- Cervical cancer therapy: current, future and anti-angiogensis targeted treatment
- (2009) Lyndsay J Willmott et al. Expert Review of Anticancer Therapy
- RAS signaling dysregulation in human embryonal Rhabdomyosarcoma
- (2009) Simone Martinelli et al. GENES CHROMOSOMES & CANCER
- MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
- (2009) F. Marampon et al. MOLECULAR CANCER THERAPEUTICS
- Anchorage-independent cell growth signature identifies tumors with metastatic potential
- (2009) S Mori et al. ONCOGENE
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Aurora kinases
- (2008) Xin Zhang CURRENT BIOLOGY
- Investigating the role of Aurora kinases in RAS signaling
- (2008) Audrey Kosik et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started